Jeff Yorio, M.D.

Jeff Yorio, M.D., is board certified in hematology, internal medicine, and medical oncology. He serves as Central Texas research site leader for Texas Oncology and Sarah Cannon Research Institute. He is active in clinical trial research for melanoma, renal cell carcinoma, prostate cancer, bladder cancer, and head and neck cancer. His research is published in the areas of melanoma, renal cell cancer, lung cancer, and colorectal cancer. Dr. Yorio served as a national and local principal investigator for multiple clinical trials. He strives to bring leading-edge treatments and new research to local patients.

A second career, medicine helps him make a bigger difference in people’s lives. He was drawn to oncology because it continues to dramatically change, and he can get to know people really well during a challenging time. Dr. Yorio educates you about your disease and treatment options, including offering new treatments and technologies. He strives to provide evidence-based medicine personalized to you. He seeks to understand your circumstances and what is important to you. So together, you can make treatments decisions specific to you.

He loves being with his family, traveling, experiencing new places and activities, jogging, tennis, and paddleboarding. He is a huge fan of anything Texas Longhorns.